Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep-Oct;36(5):2143-2148.
doi: 10.21873/invivo.12940.

c-FOS Expression Analysis in Pterygia Cell Spot Arrays

Affiliations

c-FOS Expression Analysis in Pterygia Cell Spot Arrays

Stylianos Mastronikolis et al. In Vivo. 2022 Sep-Oct.

Abstract

Background/aim: Mechanisms of c-FOS activation in the onset and progression of pterygia remain under investigation. This study aimed to comparatively analyze c-FOS proto-oncogene expression levels in neoplastic pterygia and normal epithelia.

Materials and methods: We used a liquid-based cytology assay on thirty (n=30) pterygia cell populations and normal epithelia (n=10) extracted by a smooth scraping of conjunctiva epithelia. Applying a cell spot-based technique, we constructed five (n=5) slides, each containing eight (n=8) cell spots. A modified immune-cytochemistry (ICC) assay for c-FOS protein was used. Additionally, digital image analysis was implemented to calculate c-FOS immunostaining intensity levels.

Results: High staining intensity levels of c-FOS were detected in 12/30 (40%), whereas the rest 18/30 (60%) demonstrated moderate expression. c-FOS levels were statistically significantly higher in the pterygia compared to control tissues (p=0.001). c-FOS levels in the pterygia were not associated with the sex of patients (p=0.678), the presence of recurrent lesion (p=0.390) or the location of the lesion (p=0.158). The levels of c-FOS, however, were marginally significantly affected by the morphology of the pterygia (p=0.005). More precisely, the c-FOS levels were significantly higher in pterygia with a fleshy morphology.

Conclusion: c-FOS over-expression is observed frequently in pterygia. It seems to be critically involved in the molecular mechanism of the lesion by its over-expression affecting partially their morphological features. Cell spot liquid - based array analysis is an innovative, easy to implement technique for simultaneously evaluating a broad spectrum of molecules in multiple specimens on the same slide.

Keywords: Pterygia; c-fos; cell; image analysis; ocular; oncogenes.

PubMed Disclaimer

Conflict of interest statement

The Authors have no conflicts of interest to declare in relation to this study.

Figures

Figure 1
Figure 1. c-FOS protein expression levels in pterygia fibro-endothelial cells A) Cell spot array. Note 8 spots of liquid-based cytological specimens obtained by scrapping, B) c-FOS dense expression [dark brown nuclear mainly, cytoplasmic staining pattern produced using 3-3,diaminobenzidinetetrahydrocloride (DAB) chromogen, original magnification 400×], C) Digital image analysis on a pterygia cell spot stained using a c-FOS antibody. In this progressive accurate and objective measurement process, reddish areas demonstrate different expression values, whereas green lines encircle specific areas of interest (range=0-255 continuous grey scale immunostaining intensity levels).

References

    1. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674. doi: 10.1016/j.cell.2011.02.013. - DOI - PubMed
    1. Ali J, Sabiha B, Jan HU, Haider SA, Khan AA, Ali SS. Genetic etiology of oral cancer. Oral Oncol. 2017;70:23–28. doi: 10.1016/j.oraloncology.2017.05.004. - DOI - PubMed
    1. Mishra A, Bharti AC, Saluja D, Das BC. Transactivation and expression patterns of Jun and Fos/AP-1 super-family proteins in human oral cancer. Int J Cancer. 2010;126(4):819–829. doi: 10.1002/ijc.24807. - DOI - PubMed
    1. Turatti E, da Costa Neves A, de Magalhães MH, de Sousa SO. Assessment of c-Jun, c-Fos and cyclin D1 in premalignant and malignant oral lesions. J Oral Sci. 2005;47(2):71–76. doi: 10.2334/josnusd.47.71. - DOI - PubMed
    1. Gupta S, Kumar P, Kaur H, Sharma N, Saluja D, Bharti AC, Das BC. Selective participation of c-Jun with Fra-2/c-Fos promotes aggressive tumor phenotypes and poor prognosis in tongue cancer. Sci Rep. 2015;5:16811. doi: 10.1038/srep16811. - DOI - PMC - PubMed

MeSH terms

Substances

Supplementary concepts

LinkOut - more resources